weight loss

Vivus Adds 12% in Early Trading on Qnexa Study Results

blood pressure, clinical study, diet, drug, fat, health, lipid, medical, medication, obesity, pharma, pill, placebo, qnexa, trade, vivus, vvus, weight loss

Vivus (VVUS) is up by double digits in early trading, after it says long-term data demonstrated patients treated with the investigational drug QNEXA for two years showed reductions in blood pressure and the use of antihypertensive

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Recent 52-Week Low Surpassed in Shares o...

Unisys (NYSE:UIS) traded at a new 52-week low today of $21.09. Approximately 5.1 milli ...

TransCanada: 52-Week High Recently Eclip...

TransCanada (NYSE:TRP) traded at a new 52-week high today of $51.46. So far today appr ...

Recent 52-Week High Exceeded in Shares o...

Shares of Trinity Industries (NYSE:TRN) traded today at $46.17, breaking its 52-week hi ...

Watch for Continued Gains in Shares of S...

Shares of Sasol (NYSE:SSL) traded today at $60.69, breaking its 52-week high. So far t ...

Shares of China Petroleum & Chemical Ris...

China Petroleum & Chemical (NYSE:SNP) traded today at a new 52-week high of $98.89. Ap ...

Saia Looks to Continue to Trade Above it...

Shares of Saia (NASDAQ:SAIA) traded at a new 52-week high today of $47.94. So far toda ...

Watch for Continued Gains in Shares of R...

Robert Half International (NYSE:RHI) traded today at a new 52-week high of $53.08. So ...

RPC Looks to Continue to Trade Above its...

RPC (NYSE:RES) traded at a new 52-week high today of $24.50. So far today approximatel ...

Most Popular Video News